Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American Journal of Obstetrics and Gynecology

Volumn 178, Issue 2, 1998, Pages 203-211

  Sobel, J D ^a   Faro, S ^a   Force, R W ^a   Foxman, B ^a   Ledger, W J ^a   Nyirjesy, P R ^a   Reed, B D ^a   Summers, P R ^a  

^a Departments of Infectious Disease   (United States)

Author keywords

Candida vaginitis; Diagnosis; Epidemiology; Treatment; Vulvovaginal candidiasis

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BUTOCONAZOLE; CLOTRIMAZOLE; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE; NON PRESCRIPTION DRUG; NYSTATIN; ORAL CONTRACEPTIVE AGENT; POTASSIUM HYDROXIDE; TERCONAZOLE; TIOCONAZOLE;

ARTICLE; CONTRACEPTION; CREAM; FEMALE; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PERSONAL HYGIENE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SUPPOSITORY; TABLET; TOPICAL DRUG ADMINISTRATION; VAGINA CANDIDIASIS;

EID: 0031917146     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)80001-X     Document Type: Article

References (29)

1. Berg AO Heidrich FE Fihn SD Bergman JJ Wood RW Stamm WE Establishing the cause of symptoms in women in a family practice JAMA 251 1984 620 625
2. Hurley R Delouvois J Candida vaginitis Postgrad Med J 55 1979 645 647
3. Geiger AM Foxman B Risk factors in vulvovaginal candidiasis: a case-control study among college students Epidemiology 7 1996 182 187
4. Horowitz B Edelstein SW Lippman L Sexual transmission of Candida Obstet Gynecol 69 1987 883 886
5. Spinillo A Carrata L Pizzoli G Recurrent vulvovaginal candidiasis: results of a cohort study of sexual transmission and intestinal reservoir J Reprod Med 37 1992 343 347
6. Hellburg D Zdolsek B Nilsson S Mardh PA Sexual behavior in women with repeated bouts of vulvovaginal candidiasis Eur J Epidermiol 11 1995 575 579
7. Foxman B Epidemiology of vulvovaginal candidiasis: risk factors Am J Public Health 80 1990 329 331
8. Hooten TM Roberts PL Stamm WE Effect of recent sexual activity and use of diaphragm on vaginal flora Clin Infect Dis 19 1994 274 278
9. Spinillo A Capuzzo F Nicola S Baltaro F Ferrari A Monaco A The impact of oral contraception on vulvovaginal candidiasis Contraception 51 1995 293 297
10. Barbone F Austin H Louv WC Alexander WJ A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis Am J Obstet Gynecol 163 1990 510 514
11. Reed BD Risk factors for Candida vulvovaginitis Obstet Gynecol Surv 47 1992 551 560
12. Spinillo A Capuzzo E Egbe TO Baltaro F Nicola S Piazzi G Torulopsis glabrata vaginitis Obstet Gynecol 85 1995 993 998
13. Hawes SE Hillier SL Benedetti J Stevens CE Koutsky LA Wolner-Hanssen P Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections J Infect Dis 174 1996 1058 1063
14. Sobel JD Chaim W Treatment of Candida glabrata vaginitis: a retrospective review of boric acid therapy Clin Infect Dis 24 1997 649 652
15. Vazquez JA Sobel JD Demitriou R Vaishampayan J Lynch M Zervos MJ Karyotyping of C. albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis J Infect Dis 170 1994 1566 1569
16. Schaaf VKM Perex-Stable EJ Borchardt K The limited value of symptoms and signs in the diagnosis of vaginal infections Arch Intern Med 150 1990 1929 1933
17. Ferris DG Dekle C Litaker MS Women's use of over-thecounter antifungal pharmaceutical products for gynecologic symptoms J Fam Pract 42 1996 595 600
18. Bergman JJ Berg AO Schneeweiss R Heidrich FE Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis J Fam Pract 18 1984 549 552
19. Reef SE Levine WC McNeil MM Fisher-Hoch S Holmberg SD Duerr A Treatment options for vulvovaginal candidiasis, 1993 Clin Infect Dis 20 Suppl 1 1995 S80 S90
20. Tooley PJ Patient and doctor preferences in the treatment of vaginal candidiasis Practitioner 229 1985 655 662
21. Sobel JD Brooker D Stein GE Thomason J Wermeling DP Weinstein L Single oral dose fluconazole compared with conventional topical therapy of Candida vaginitis Am J Obstet Gynecol 172 1995 1263 1268
22. Houang ET Chappatte O Byrne D Macrae PV Thorpe JE Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis Antimicrob Agents Chemother 34 1990 909 910
23. Sobel JD Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy N Engl J Med 315 1986 1455 1458
24. Summer PR Clinical evidence of a dermatologic etiology for recurrent vulvovaginal candidiasis in immunocompetent patients Proceedings of the Investigational Summit on Cutaneous Antifungal Therapy 1993 Oct 23; San Francisco, California 1993 The Summit San Francisco
25. Fong IW The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole Genitourin Med 68 1992 174 176
26. Fidel PJ Jr Sobel JD Immunopathogenesis of recurrent vulvovaginal candidiasis Clin Microbiol Rev 9 1996 335 348
27. Sobel JD Treatment of recurrent vulvovaginal candidiasis with maintenance fluconazole Int J Gynaecol Obstet 37 1992 17 34
28. Hilton E Isenberg HD Alperstein P France K Borenstein M Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis Ann Intern Med 116 1992 353 357
29. Rex JH Rinaldi MG Pfaller MA Resistance of Candida species to fluconazole Antimicrob Agents Chemother 39 1995 1 8